30 years of experience in CNS drug development – The fastest track from molecule to clinic

Expertise in CNS diseases

    • Alzheimer’s disease

    • Parkinson’s disease

    • Orphan neurodegenerative disorders

    • Cerebrovascular diseases

    • Psychiatric diseases

Profound knowledge of requirements

    • Pharmacology

    • ADME

    • Toxicology

    • Regulatory issues (IND/ CTA)

    • Clinical trials

Full coverage of client needs

  • Designing most efficient individualized development plan

  • Providing an outstanding network of KOLs in different fields of CNS diseases

  • Fastest reaction time  

  • Competitive pricing

WE KNOW WHAT YOU NEED 

BECAUSE WE DID IT ALREADY 

MORE THAN ONCE

WE KNOW WHAT YOU NEED 

BECAUSE WE DID IT ALREADY 

MORE THAN ONCE

Our service is expertise

We understand drug targets and mechanisms of action
We know about challenges for a CNS compound
We have experience in translational research ,
Years of experience in academia, pharmaceutical and CRO industry and
Practical experience with:

    • Neuronal tissue culture
    • Induced  and transgenic disease models
    • Drug metabolism and Pharmacokinetics
    • Safety pharmacology and toxicology
    • Clinical trials – Biomarkers – Imaging – Neuropsychological testing

       

WE ARE DEDICATED TO YOUR SUCCESS

Aquila CTPV

Because safety comes first !
By using Aquila CTPV in your trial, you have taken a huge leap into the future of automated safety reporting, medical case reviewing and efficient data handling.

Meet your Experts

Leading CNS for decades

With well over 25 years in Neuroscience and 40+ years in research, our network contains eminent authorities in the field of Neuroscience, Alzheimers and overall CNS. This way we can ensure:

  • Fastest reaction time
  • Competetive Pricing
  • Most reliable Service providers
  • Most efficient individualized development plans